Sanofi and the firm with which it's co-developing alirocumab disclosed that regulators want some patients to be assessed for neurocognitive side effects.
Draftfcb Healthcare has rebranded to FCB Health, and has also acquired UK healthcare agency Halesway, effective immediately, the agency announced today
India's Ranbaxy logged yet another recall, while the country's stance on patent protection keeps the industry on edge.
The JD Powers survey shows health insurance communication opportunities.
Lonnel Coats is leaving after 18 years with the company.
Hospitals are contemplating financial incentives—as in fines or less support—for patients who could have signed up for health insurance but opted not to.
Biopharma lobbying groups attacked the president's FY 2015 budget as soon as the ink had dried on the $3.9-trillion document
The drugmaker's annual report indicates the company is concerned that an investigation into its marketing could dissuade doctors from prescribing Juxtapid.
Advocates say the National Institutes of Health is working with 22% less buying power than it had 11 years ago.
Queensland, Australia, researchers find the risk of high-grade cervical abnormalities fell 46% among women who had received all three doses of the HPV vaccine.